ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients - a prospective study of accuracy for prediction of length of stay in the ICU.

Ann Intensive Care 2014 8;4:19. Epub 2014 Jul 8.

Surgical Intensive Care Medicine, University Hospital of Zurich, Raemistrasse 100, Zurich, CH-8091, Switzerland ; Swiss Paraplegic Center, Nottwil, Switzerland.

Background: Prognostic abilities of medical parameters, which are scoring systems, measurements and biomarkers, are important for stratifying critically ill patients. Indocyanine green plasma disappearance (ICG-PDR) is an established clinical tool for the assessment of liver perfusion and function. Copeptin, MR-proANP and pro-ADM are biomarkers whose prognostic value is still unclear. The goal of this prospective study was to evaluate ICG-PDR, copeptin, MR-proANP and pro-ADM to predict prolonged length of stay (pLOS) in the ICU.

Methods: This study was conducted as a prospective single center study including 110 consecutively admitted ICU patients. Primary endpoint was prolonged length of stay (pLOS) in the ICU, defined as more than three days of stay there.

Results: ROC analysis showed an AUC of 0.73 for ICG-PDR, 0.70 for SAPS II, 0.65 for MR-proANP, 0.64 for pro-ADM and 0.54 for copeptin for pLOS in the ICU.

Conclusions: The prediction of pLOS in the ICU might be better by means of ICG-PDR than with the new biomarkers copeptin, MR-proANP or pro-ADM. Nevertheless, there is more need for research to evaluate whether ICG-PDR is an overall prognostic marker for pLOS.

Trial Registration: (ClinicalTrials.gov number, NCT01126554).

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13613-014-0019-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100565PMC
July 2014
26 Reads

Publication Analysis

Top Keywords

length stay
16
prolonged length
12
copeptin mr-proanp
12
mr-proanp pro-adm
12
plos icu
8
evaluate icg-pdr
8
critically ill
8
biomarkers prognostic
8
prospective study
8
ill patients
8
stay plos
8
stay
5
icg-pdr
5
including 110
4
110 consecutively
4
study including
4
center study
4
prospective single
4
single center
4
consecutively admitted
4

References

(Supplied by CrossRef)

V Stevens et al.
Infect Control Hosp Epidemiol 2012

JR Gall Le et al.
JAMA 1993

L Minne et al.
Crit Care 2008

EE Vasilevskis et al.
Chest 2009

Y Sakr et al.
J Eval Clin Pract 2012

P Faybik et al.
Liver Transpl 2004

SG Sakka et al.
Chest 2002

J Forestier et al.
Eur J Gastroenterol Hepatol 2010

CN Liguori de et al.
Eur J Surg Oncol 2009

CH Nickel et al.
BMC Med 2012

M Thibonnier et al.
Endocrinology 1997

Similar Publications